Clinica Chimica Acta:CDT对监测妊娠期慢性酒精滥用的参考值

2020-06-24 MedSci原创 MedSci原创

碳水化合物缺乏转铁蛋白(CDT)是妊娠期监测酒精使用最常用的生物标志物之一。

碳水化合物缺乏转铁蛋白(CDT)是妊娠期监测酒精使用最常用的生物标志物之一。然而,它在这方面的有效应用受到CDT值在怀孕期间(甚至在禁欲妇女中)的生理进行性增长的限制,在妊娠晚期,CDT值可以达到接近或超过临床和法医诊断中通常采用的截断值。因此,本研究旨在重新评估妊娠期CDT参考值。

CDT分析采用经验证的HPLC-UV Vis方法对284例生理妊娠妇女血清样本和370例普通人群(对照组)非妊娠妇女血清样本进行。所有样本还进行了GGT排除酒精滥用的测试。采用MedCalc®统计软件进行统计分析。

根据Horn和Pesce稳健方法对具体参考浓度进行了重新定义。所得到的CDT上参考值分别为1.45%、2.01%和2.05%,分别在妊娠第一、第二和第三个月。

为了预防孕妇和胎儿产前酒精暴露并发症的发生,已经提出使用酒精生物标志物,包括CDT。然而,这种用于监测怀孕期间酒精使用的生物标记,迄今为止一直采用与一般人群相同的截止值,而没有考虑到其在整个怀孕期间的生理价值的逐渐增加。在本研究中,我们对每个妊娠期的CDT参考浓度进行了重新评估。

原始出处:

Federica Bortolotti,Ricciarda Raffaelli,CDT reference values for monitoring chronic alcohol abuse in pregnancy

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1701596, encodeId=af0e1e0159674, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Sun Jun 28 02:22:42 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849951, encodeId=8bdc18499513e, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Aug 09 03:22:42 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251257, encodeId=8827125125e26, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Fri Jun 26 13:22:42 CST 2020, time=2020-06-26, status=1, ipAttribution=)]
    2020-06-28 zchen
  2. [GetPortalCommentsPageByObjectIdResponse(id=1701596, encodeId=af0e1e0159674, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Sun Jun 28 02:22:42 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849951, encodeId=8bdc18499513e, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Aug 09 03:22:42 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251257, encodeId=8827125125e26, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Fri Jun 26 13:22:42 CST 2020, time=2020-06-26, status=1, ipAttribution=)]
    2020-08-09 windight
  3. [GetPortalCommentsPageByObjectIdResponse(id=1701596, encodeId=af0e1e0159674, content=<a href='/topic/show?id=bedc665998e' target=_blank style='color:#2F92EE;'>#滥用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66599, encryptionId=bedc665998e, topicName=滥用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea1030383785, createdName=zchen, createdTime=Sun Jun 28 02:22:42 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849951, encodeId=8bdc18499513e, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Aug 09 03:22:42 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251257, encodeId=8827125125e26, content=<a href='/topic/show?id=90494486837' target=_blank style='color:#2F92EE;'>#妊娠期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44868, encryptionId=90494486837, topicName=妊娠期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Fri Jun 26 13:22:42 CST 2020, time=2020-06-26, status=1, ipAttribution=)]